Malignancy and renal disease.

作者: Mohit Kapoor , Germaine Z. Chan

DOI: 10.1016/S0749-0704(05)70199-8

关键词: OncologyInternal medicineMalignancyChemotherapeutic drugsCancerDiseasePathologyElectrolyte DisorderMedicine

摘要: A variety of renal diseases and electrolyte disorders may be associated with various malignancies or treatment malignancy chemotherapeutic drugs radiation. This article reviews disease in cancer patients, which constitutes a major source morbidity mortality.

参考文章(207)
JM Davis, SD Rowley, HG Braine, S Piantadosi, GW Santos, Clinical toxicity of cryopreserved bone marrow graft infusion. Blood. ,vol. 75, pp. 781- 786 ,(1990) , 10.1182/BLOOD.V75.3.781.781
Toskes P, Walser M, Mahaffey J, Connor Tb, Williams Jb, Martin Lg, Parathyroid function during chronic magnesium deficiency. The Johns Hopkins medical journal. ,vol. 131, pp. 100- ,(1972)
S P Wilkinson, R Williams, M J Weston, V Parsons, Dialysis in the treatment of renal failure in patients with liver disease. Clinical Nephrology. ,vol. 8, pp. 287- 292 ,(1977)
Robert Mark Black, Burton David Rose, Manual of clinical problems in nephrology ,(1988)
Arthur Greenberg, Primer on Kidney Diseases ,(2009)
Cancer chemotherapy reports CA: A Cancer Journal for Clinicians. ,vol. 23, pp. 182- 183 ,(1973) , 10.3322/CANJCLIN.23.3.182
Richard A. Olshen, Craig E. Pfeifle, Wally E. Wung, Stephen B. Howell, Intraperitoneal cis-diamminedichloroplatinum with systemic thiosulfate protection. Cancer Research. ,vol. 43, pp. 1426- 1431 ,(1983)
C E Pfeifle, S B Howell, R D Felthouse, T B Woliver, P A Andrews, M Markman, M P Murphy, High-dose cisplatin with sodium thiosulfate protection. Journal of Clinical Oncology. ,vol. 3, pp. 237- 244 ,(1985) , 10.1200/JCO.1985.3.2.237
Robert Branch, John Gerkens, Hugo Heidemann, K Jackson, Edwin, Effect of aminophylline on amphotericin B nephrotoxicity in the dog. Journal of Pharmacology and Experimental Therapeutics. ,vol. 224, pp. 609- 613 ,(1983)
D C Dobyan, J Levi, C Jacobs, J Kosek, M W Weiner, Mechanism of cis-platinum nephrotoxicity: II. Morphologic observations. Journal of Pharmacology and Experimental Therapeutics. ,vol. 213, pp. 551- 556 ,(1980)